Bafna Pharmaceuticals Limited

BAFNAPH

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202627

    Quarter₹ croreYoY
    Jun 202433-20.6%
    Sept 202440-0.9%
    Dec 202433+16.7%
    Mar 202539-5.6%
    Jun 202535+4.0%
    Sept 202535-12.0%
    Dec 202538+15.4%
    Mar 202642+8.1%
    Jun 202627-23.2%
  • ₹ crore

    Jun 20262

    Quarter₹ crore
    Jun 20240.51
    Sept 20241
    Dec 20240.19
    Mar 20251
    Jun 20250.60
    Sept 20251
    Dec 20251
    Mar 20262
    Jun 20262
  • ₹ crore

    Jun 202628

    Quarter₹ crore
    Jun 202434
    Sept 202441
    Dec 202433
    Mar 202540
    Jun 202535
    Sept 202537
    Dec 202540
    Mar 202644
    Jun 202628
  • Cost structure
  • ₹ crore

    Jun 20266

    Quarter₹ crore
    Jun 20245
    Sept 20245
    Dec 20245
    Mar 20256
    Jun 20256
    Sept 20255
    Dec 20255
    Mar 20265
    Jun 20266
  • ₹ crore

    Jun 202628

    Quarter₹ crore
    Jun 202434
    Sept 202439
    Dec 202432
    Mar 202537
    Jun 202532
    Sept 202534
    Dec 202538
    Mar 202641
    Jun 202628
  • Exceptional items and tax
  • ₹ crore

    Jun 20260.08

    Quarter₹ crore
    Jun 2024-0.72
    Sept 20243
    Dec 20240.95
    Mar 20251
    Jun 20253
    Sept 20253
    Dec 20252
    Mar 20263
    Jun 20260.08
  • ₹ crore

    Jun 20260

    Quarter₹ crore
    Jun 20240
    Sept 20240
    Dec 20240
    Mar 20250
    Jun 20250
    Sept 20250
    Dec 20250
    Mar 2026-0.13
    Jun 20260
  • Profit
  • ₹ crore

    Jun 20260.08

    Quarter₹ croreYoY
    Jun 2024-0.72-111.4%
    Sept 20243+5.4%
    Dec 20240.95+132.2%*
    Mar 20251-9.9%
    Jun 20253+568.3%*
    Sept 20253+19.4%
    Dec 20252+93.8%
    Mar 20263+109.7%
    Jun 20260.08-97.8%
  • Per share
  • ₹ per share

    Jun 20260.03

    Quarter₹ per share
    Jun 2024-0.31
    Sept 20241.11
    Dec 20240.40
    Mar 20250.55
    Jun 20251.43
    Sept 20251.32
    Dec 20250.78
    Mar 20261.16
    Jun 20260.03
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
334033393535384227
Revenue YoY-20.6%-0.9%+16.7%-5.6%+4.0%-12.0%+15.4%+8.1%-23.2%
0.5110.1910.601122
344133403537404428
Cost structure
555665556
343932373234384128
Exceptional items and tax
-0.7230.95133230.08
0000000-0.130
Profit
-0.7230.95133230.08
Net profit YoY-111.4%+5.4%+132.2%*-9.9%+568.3%*+19.4%+93.8%+109.7%-97.8%
Per share
-0.311.110.400.551.431.320.781.160.03

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.